Metamizole Noridem

Metamizole Sodium, the active ingredient in Metamizole Noridem, is a pyrazolone presented as a sterile solution for intramuscular and intravenous use. It is employed to relieve moderate to severe pain and to reduce fever in adult patients when other treatments are insufficient. GNH USA supplies Metamizole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Metamizole Noridem is a pyrazolone analgesic and antipyretic used in acute pain and fever management. - Acute pain: provides rapid relief of moderate to severe pain. - Postoperative pain: helps control pain after surgical procedures. - Fever: reduces elevated body temperature associated with infection or inflammation.

Metamizole Noridem may cause a range of adverse reactions.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the site of administration. - Nausea: transient feeling of queasiness. - Dizziness: occasional light‑headedness. - Transient hypotension: brief drop in blood pressure after injection.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells, requiring immediate medical attention. - Anaphylactic reaction: rare but potentially life‑threatening hypersensitivity. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: abnormal liver enzyme elevations.

When using Metamizole Noridem, consider the following safety measures. - Monitor blood counts: regular hematologic testing is advised to detect agranulocytosis early. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Caution with renal impairment: adjust use in patients with reduced kidney function. - Use carefully in the elderly: increased susceptibility to adverse effects. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metamizole Noridem can interact with several drug classes.

Major Interactions (Avoid): - Other NSAIDs or COX inhibitors: increased risk of bleeding and renal toxicity. - Anticoagulants (e.g., warfarin): heightened anticoagulant effect and bleeding risk. - Allopurinol: potential for severe skin reactions.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance hypotensive effects. - Diuretics: possible reduction in renal perfusion. - Lithium: may increase lithium serum levels.